Lifevantage Corporation (LFVN): Price and Financial Metrics
Lifevantage Corporation (LFVN)
Today's Latest Price: $14.75 USD
Updated May 22 4:00pm
Add LFVN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 14 in Medical - Consumer Goods
See all "A" rated Strong Buy stocks
LFVN Stock Summary
- Lifevantage Corp's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 95.48% of US listed stocks.
- Of note is the ratio of Lifevantage Corp's sales and general administrative expense to its total operating expenses; 86.98% of US stocks have a lower such ratio.
- The ratio of debt to operating expenses for Lifevantage Corp is higher than it is for about merely 5.88% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Lifevantage Corp are JYNT, KFRC, ARCB, VNCE, and HSII.
- LFVN's SEC filings can be seen here. And to visit Lifevantage Corp's official web site, go to www.lifevantage.com.
LFVN Stock Price Chart More Charts
LFVN Price/Volume Stats
| Current price | $14.75 | 52-week high | $17.25 |
| Prev. close | $14.37 | 52-week low | $7.75 |
| Day low | $14.29 | Volume | 61,485 |
| Day high | $14.77 | Avg. volume | 103,413 |
| 50-day MA | $12.51 | Dividend yield | N/A |
| 200-day MA | $13.76 | Market Cap | 211.12M |
Lifevantage Corporation (LFVN) Company Bio
LifeVantage Corporation identifies, researches, develops, and distributes nutraceutical dietary supplements and skin care products. The company is based in Sandy, Utah.
LFVN Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $14.75 | $9.26 | -37% |
We started the process of determining a valid price forecast for Lifevantage Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Lifevantage Corp ranked in the 33th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Lifevantage Corp, consider:
- The business' balance sheet suggests that 1% of the company's capital is sourced from debt; this is greater than merely 4.9% of the free cash flow producing stocks we're observing.
- The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than only 0% of stocks in its sector (Consumer Defensive).
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -38% |
| 1% | -38% |
| 2% | -37% |
| 3% | -37% |
| 4% | -36% |
| 5% | -35% |
For other companies in the Consumer Defensive that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as LFVN, try COST, INGR, MENB, CHGG, and HLF.
Loading social stream, please wait...